Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 3.2B | 3.3B | 3.3B | 3.5B |
Cost of revenue | 2.3B | 2.4B | 2.4B | 2.5B |
Gross profit | 902M | 882M | 932M | 1.0B |
Operating expense | ||||
Research & development | 24M | 23M | 22M | 25M |
Selling general and admin | 656M | 680M | 601M | 645M |
Other operating expenses | 19M | 522M | 55M | 21M |
Operating income | 228M | -101M | 274M | 338M |
Non operating interest income | ||||
Income | 2M | 6M | 3M | 4M |
Expense | 60M | 76M | 67M | 73M |
Other income expense | — | — | — | — |
Pretax income | 185M | -175M | 208M | 272M |
Tax provision | 40M | -2M | 50M | 59M |
Net income | 145M | -173M | 158M | 213M |
Basic EPS | 1.9 | -2.2 | 2.1 | 2.8 |
Diluted EPS | 1.9 | -2.2 | 2.1 | 2.8 |
Basic average shares | 76.9M | 76.9M | 76.9M | 76.8M |
Diluted average shares | 76.9M | 76.9M | 76.9M | 76.8M |
EBITDA | 419M | 369M | 444M | 514M |
Net income from continuing op. | 228M | -101M | 274M | 338M |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |